Charles De Gaspe Beaubien, Groupize.ai co-founder talks about launch of DSai™ digital sign-in and compliance with AI, SAP Concur & MedPro integrations, and the impact for Life Sciences organizations
In the fast-moving world of Life Sciences, innovation is often measured in scientific breakthroughs and regulatory approvals. But sometimes, it’s the unglamorous operational hurdles—like documentation and compliance—that demand the most urgent innovation. Charles De Gaspe Beaubien, the Co-founder and CCO of Groupize.ai, knows this all too well.
As the category leader in AI-powered meeting and event management, Groupize.ai has earned the trust of Fortune 500 companies, government agencies, and leading Life Sciences organizations by transforming how teams plan, manage, and govern meetings at scale. Built on a foundation of intelligent automation, seamless integrations, and real-time compliance,
Groupize.ai is widely recognized for delivering practical, enterprise-grade innovation. With the launch of DSai™, that same proven platform is now being applied to one of Life Sciences’ most frustrating pain points: healthcare professional (HCP) documentation.
In this exclusive interview, Charles opens up about the creation of DSai™—an AI-powered digital sign-in and compliance platform purpose-built for Life Sciences—and why the time for change is now.
Q: Charles, tell us about what you’re announcing with DSai and what it represents for the industry.
Charles De Gaspe Beaubien: Today, we’re sharing the culmination of years of focused development: DSai, the industry’s first AI-powered, end-to-end digital sign-in and compliance automation solution for Life Sciences. Built through deep collaboration with the world’s most recognized Life Sciences leaders, DSai finally solves one of our industry’s most persistent pain points.
But this isn’t really a story about AI or breakthrough technology. It’s about solving something that should never have been so difficult in the first place: HCP sign-ins.
Q: Let’s get to the core—what exactly is the problem you set out to solve?
Charles: In Life Sciences, few processes cause more frustration than HCP documentation requirements. What should be straightforward has become a tangle of problems affecting every department—compliance teams drowning in manual verification, sales reps losing 5+ hours weekly chasing signatures, and auditors finding endless discrepancies in handwritten forms.
Walk into any pharmaceutical company today, and you’ll hear the same story. Field representatives spend more time hunting for NPI numbers and squinting at doctor handwriting than actually selling. Compliance officers lose sleep over incomplete documentation. Expense reports bounce back endlessly for missing HCP information. And when audit time comes, everyone holds their breath.
For decades, Life Sciences organizations have relied on paper sign-in sheets, manual data entry, and post-event reconciliation to meet Sunshine Act and Open Payments requirements. These processes don’t just create compliance risk—they steal valuable time from the work that actually drives revenue: quality interactions with healthcare providers.
Q: How is DSai fundamentally different from other tools out there?
Charles: DSai isn’t just another digital tool. We spent years in R&D, investing millions and collaborating with industry leaders to create something truly different: an AI-powered solution that handles HCP documentation seamlessly, regardless of how healthcare professionals choose to sign in.
Whether doctors prefer QR codes, mobile apps, or traditional signatures, DSai transforms everything into perfect reconciliation digital records. Our AI-powered optical character recognition captures handwritten signatures with precision. Instant MedPro integration validates HCP licenses in real-time. Direct SAP Concur connectivity pushes spend data automatically, eliminating manual entry entirely.
The result? Sales reps get 5 hours back each week. Compliance teams sleep better. Auditors find nothing to complain about. And honestly, nobody even notices the technology anymore—it just works. Which is exactly the point.
Q: Why is the timing of this solution so important for Life Sciences right now?
Charles: As regulatory scrutiny intensifies around HCP interactions, Life Sciences organizations can no longer afford the compliance risks that come with manual processes. The cost of documentation errors—regulatory investigations, financial penalties, reputational damage—far exceeds any technology investment.
But more than compliance, this is about empowering your field teams. Every minute spent chasing signatures is a minute not spent building relationships with healthcare providers. Every compliance headache is a distraction from advancing treatments that save lives.
Q: Can you share some real-world impact or results you’ve already seen?
Charles: We’re already seeing the transformation DSai brings:
- 95% reduction in manual compliance tasks
- 5+ hours weekly returned to sales representatives
- 100% audit accuracy across all tracked events
- Zero expense report rejections for missing HCP data
- Seamless adoption with minimal change management
But the numbers only tell part of the story. What really matters is watching sales teams refocus on revenue-generating activities while compliance officers finally get uninterrupted sleep.
Q: Was DSai built solely by your team, or did you involve industry stakeholders?
Charles: DSai wasn’t built in isolation. We collaborated with respected Life Sciences leaders who helped shape every feature, validate every process, and ensure the solution meets the industry’s most demanding requirements. This isn’t experimental technology—it’s proven innovation, tested and refined by the organizations that set industry standards.
Q: What’s next for DSai and for Groupize.ai in the Life Sciences space?
Charles: We’re accelerating DSai’s adoption across pharmaceutical companies, medical device manufacturers, and biotech organizations worldwide. Built on Groupize.ai’s proven platform—quietly revolutionizing meetings management for over a decade—DSai represents the natural evolution of our commitment to solving real customer problems.
Our mission remains clear: ensuring every Life Sciences organization can focus on advancing healthcare innovation without worrying about compliance accuracy or administrative burden.
Because at the end of the day, Life Sciences isn’t just about regulatory requirements or operational efficiency. It’s about developing treatments that change lives. And that requires teams focused on what matters most—not paperwork.
That’s what DSai delivers. And that’s why we’re just getting started.
Q: For those interested in learning more, what’s the best next step?
Charles: To see how DSai can transform HCP compliance at your organization, we invite you to contact us today for a live demo.
We will also be at Informa’s Transparency & HCP Engagement 2025 event August 12-14, The Ritz-Carlton, Tysons Corner McLean, VA.
Final Thoughts:
With DSai, Groupize.ai continues to prove why it’s a trusted innovator across regulated industries. By extending its expertise from meeting automation to compliance transformation, the company isn’t just streamlining operations—it’s freeing Life Sciences teams to focus on what truly matters: advancing care.
